Current Research

Addictive health disorders have a broad impact on the lives of those who suffer from these conditions, as well as their families and communities. Investigators from the PARCKA program engage in research in a number of different areas that span the continuum of health care, treatment, and services. Investigators specialize in behavioral health services research, which includes epidemiological, observational, experimental, quasi-experimental, implementation, and evaluative research. Recognizing the vast impact of addiction, PARCKA investigators focus on populations that have disproportionate risk for substance use, such as individuals who are homeless, veterans, suffer from chronic pain or psychiatric illness, and/or identify as LGBTQIA.

Greater Intermountain Node

The Greater Intermountain Node (GIN) is housed within PARCKA. The GIN leverages robust institutional commitment and infrastructure, institutional centers focused on addiction-related research, and training programs with strong regional and national connections to clinicians, educators, other institutions and organizations, and community stakeholders. GIN has dedicated space, staff, and faculty to accomplish its missions. The GIN brings particular expertise in three areas of opioid addiction research to the Utah, regional, and national communities: 

  • Research within non-addiction specialty health care settings
  • Addiction and opioid research within large health systems of care
  • Implementation science and approaches to bring addiction evidence based research to practice.

Current Research: 

A Foundation to Examine Reasons for Discontinuation for Buprenorphine Care in the Veterans Health Administration. NIH/NIDA: 3UG1DA040316-04S3. Principal Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Advancing VA interdisciplinary Addiction Training, Research, and Scholarship (AVIATORS). VA Office of Academic Affiliations. Co-Director, Co-Principal Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Center for Opioid Policy Research. NIH/NIDA. Consultant: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Comparative Effectiveness of Alcohol and Drug Treatment in HIV-infected Veterans. NIAAA: R01 AA022886. Co-Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Effectiveness of a Rescue Medication in Preventing Opioid Overdose in Veterans. VA HSR&D. Consultant: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO
Enhancing the Access and Quality of Medication-Assisted Treatment (MAT) for Individuals with Opioid Use Disorder (OUD) in Rural Pennsylvania’s Medicaid Primary Care Practices. AHRQ: 1R18HS025072. Co-Investigator, Medical Director, Evaluator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO. Co-Investigator: Gerald Cochran, Ph.D., MSW.
Examining the quality of opioid use disorder treatment in a Medicaid research network. NIH, NIDA. Co-Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Experiences with HUDVAH Services among male, female, and transgender Veterans. VA: National Center on Homelessness among Veterans. Co-Investigator, Mentor: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Facilitation of the Stepped Care Model and Medication Treatment for Opioid Use Disorder. VA: QUERI PII PEC 19-001, VA: QUERI. Principal Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Health Outcomes and Healthcare Use among Transgender Veterans. HSR&D 14-408. Primary Mentor: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Implementation and Evaluation of a Multifaceted Provider Support Initiative to Improve Access to Opioid Use Disorder Treatment in Primary Care Settings. VA QUERI PII 18-181. Co-Principal Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Improving Care for Homeless Veterans: Integration of Mental Health Services in Primary Care Settings. University of Utah Center for Clinical and Translational Science. KL2 Mentored Career Scholars Program. Principal Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Improving housing outcomes for homeless Veterans. VA: HSR&D. Co-Investigator; Advisor; Mentor: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Improving Implementation and Outcomes of Office-Based Opioid Dependence Treatment in the VA, Buprenorphine in the VA (BIV) Initiative, and Medication Addiction Treatment in the VA (MAT-VA). VA: VACO/ CESATE. Principal Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Integrative Psychosocial Group Treatment (IPGT): A Randomized Pilot Trial of a Harm Reduction and Preventative Approach for Patients with Chronic Pain at Risk for Opioid Misuse. Staunton Farm Foundation. Co-Investigator: Gerald Cochran, Ph.D., MSW.
Maternal and neonatal effects of maternal initiation and maintenance of opioid medication treatment. University of Utah’s Vice President’s Clinical and Translational Research Scholars Program, Utah Women’s Reproductive Health Research Career Development Program. Principal Investigator: Marcela Smid, MD. Co-Investigator, Primary Mentor: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO
Opioid Agonist Therapy in Medicaid – Impact of State Policies on Quality. NIH/NIDA. Co-Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Optimizing Pregnancy and Treatment Interventions for Moms 2.0. 1R01CE002996-01, CDC. Principal Investigator: Gerald Cochran, Ph.D., MSW. Co-Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Prescription opioid misuse: Pharmacist-delivered intervention at point of service. NIDA. Principal Investigator: Gerald Cochran, Ph.D., MSW.
Primary Care Quality and Homeless Service tailoring (PCQ-Host). HSR&D: IIR 15-095. Site Principal Investigator, Co-Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Non-Cancer Pain in Primary Care. PCORI: R-1609-36881PCORI. Site-Principal Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO; Co-Investigator: Gerald Cochran, Ph.D., MSW.
Stratification Tool for Opioid Risk Management (STORM) Implementation Program Evaluation. VA HSR&D: SDR 16-193. Co-Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Testing a Novel Strategy to Improve Implementation of Mediation-Assisted Treatment for Veterans with Opioid use Disorders in Low Performing Facilities. VA HSR&D: IIR 16-145 Co-Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Using machine learning to predict problematic opioid use and opioid overdose. National Institute on Drug Abuse. Co-Investigator: Gerald Cochran, Ph.D., MSW. Consultant: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
VAPHS's Interdisciplinary Addiction Program for Education and Research (VIPER). VA Office of Academic Affiliations. Co-Director, Co-Principal Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO.
Vulnerable Veteran – Innovative Patient Aligned Care Team (VIP): a VISN 19-IDEAS/COIN Collaborative Clinical and Evaluative Initiative. VA: VISN 19 and VA Salt Lake City. Principal Investigator: Adam Gordon, MD, MPH, FACP, DFASAM, CMRO. Co-Investigator: Gerald Cochran, Ph.D., MSW.

 

Now Recruiting!

Optimizing Pregnancy & Treatment Interventions for Moms 2.0:

This study will further develop and refine interventions to prevent postnatal drug use relapse, establish protocols for a multisite randomized clinical trial, and pilot test the finalized intervention and multisite protocols within two health systems with high rates of opioid use disorder among pregnant women.
Sponsor: Center for Disease Control
Principal Investigator: Gerald Cochran, PhD, MSW
If interested in participating or learning more, contact Kristi Carlston at kristi.carlston@hsc.utah.edu or (801) 213-0799.